Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class ASSE: 600332

Announcement on Progress in Guangzhou Guangyao Phase II Fund Equity Investment Partnership (Limited Partnership) Acquiring an 11.04% Equity Interest in Nanjing Pharmaceutical Company Limited

· Issued by Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A via Shanghai Stock Exchange
Announcement on Progress in Guangzhou Guangyao Phase II Fund Equity Investment Partnership (Limited Partnership) Acquiring an 11.04% Equity Interest in Nanjing Pharmaceutical Company Limited

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis